This guide covers everything you need to know about GLP-1 appetite suppression timelines, what to expect during your first weeks, and how to make the most of your treatment journey
However, our analysis revealed the opposite: patients with diabetes who were exposed to GLP-1 RAs had a substantially higher risk of being diagnosed with nAMD, with a shorter time to diagnosis, compared with propensity-matched patients who were unexposed. The researchers also revealed that this finding comes amid numerous reports in other literature of unexpected worsening of diabetic retinopathy following a rapid reduction in blood glucose levels
The standard dose escalation schedule gradually increases doses to minimize side effects, but the first 8-16 weeks typically require the most vigilant hydration and prevention efforts
The pattern held up fairly consistently regardless of a patients age, sex, race, weight, or which specific GLP-1 drug they took, though researchers noted some of those breakdowns relied on smaller numbers and should be read cautiously
But as more companies develop similar GLP-1 drugs, Novo Nordisk may have to rely more on its patents to stay ahead
Lawsuits do not stop the enforcement of existing FDA regulations unless a court issues an injunction or a stay, which has not happened for the broader industry
,aspect=ignore)
